Name | 7-[2-[[2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]amino]ethyl]-1,3-dimethylpurine-2,6-dione |
---|---|
Synonyms |
7-{2-[2-(3,4-dihydroxyphenyl)-2-hydroxyethylamino]-ethyl}-theophylline
Theodrenalina [DCIT] 7-(2-(2-Hydroxy-2-(3,4-dihydroxyphenyl)ethylamino)ethyl)theophylline Noradrenaline theophylline 7-{2-[2-(3,4-dihydroxy-phenyl)-2-hydroxy-ethylamino]-ethyl}-1,3-dimethyl-3,7-dihydro-purine-2,6-dione Theodrenalinum [INN-Latin] theodrenaline Norphedrinoethyltheophylline D 470 Teodrenalina [INN-Spanish] |
Description | Theodrenaline is a cardiac stimulant, also acts as an anti-hypotensive agent together with cafedrine. |
---|---|
Related Catalog | |
In Vitro | Akrinor evokes a positive inotropic effect in human atrial trabeculae via stimulation of β-adrenoceptors (AR)[1]. |
In Vivo | AkrinorTM produces significant potentiation of FSK effects, conceivable by PDE-inhibition, only at very high, clinically irrelevant concentrations of 420 mg/L[1]. |
References |
Density | 1.51g/cm3 |
---|---|
Boiling Point | 723.6ºC at 760mmHg |
Molecular Formula | C17H21N5O5 |
Molecular Weight | 375.37900 |
Flash Point | 391.4ºC |
Exact Mass | 375.15400 |
PSA | 134.54000 |
Vapour Pressure | 5.61E-22mmHg at 25°C |
Index of Refraction | 1.696 |
Storage condition | 2-8℃ |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|